Dana-Farber Cancer Institute

Continuing Medical Education

    In this section
    cme-participants-653x447.jpg

    Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, shares advances in cancer research and treatment with the healthcare community through continuing medical education (CME) courses.

    Dana-Farber CME courses, offered in conjunction with Harvard Medical School or Partners HealthCare Office of Continuing Professional Development, which are both accredited by the Accreditation Council for Continuing Medical Education (ACCME), provide continuing medical education for physicians. These educational activities have been designated as credit towards the AMA Physician's Recognition Award.

    Upcoming Courses

    ASH 2025 Highlights
    January 24, 2026
    Course Format: Live Virtual
    This course is designed to educate clinicians on new developments in the diagnosis and treatment of all blood cancers, highlighting the most clinically relevant data presented at the ASH Annual Meeting.
    View course and register

    Updates to Cancer Survivorship: Optimizing Care and Outcomes
    Available until January 28, 2028
    Course format: Online; self-paced
    This course is designed to educate clinicians on the latest advancements in cancer survivorship care, focusing on evidence-based strategies to enhance patient outcomes and address the unique needs of diverse cancer survivors.
    View course and register

    Grand Rounds

    Dana-Farber is a teaching affiliate of Harvard Medical School and founder of Dana-Farber/Harvard Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute.

    Visit our calendar of on-site educational opportunities for healthcare professionals, researchers and scientists, available through Dana-Farber and partnering institutions.